1. A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China. Issue 3 (4th March 2023) Authors: Zheng, Zhiwei; Zhu, Gaofeng; Cao, Xueqiong; Cai, Hongfu; Zhu, Huide Journal: Expert review of clinical pharmacology Issue: Volume 16:Issue 3(2023) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗